A Personalized Self-Management Program for Older Adults With Chronic Pain and Negative Emotions
2 other identifiers
interventional
157
1 country
1
Brief Summary
This study examines the effects of PATH-Pain on emotion regulation to improve self-management of pain and pain-related disability in older adults with chronic pain, negative emotions, and cognitive impairment. Half the participants will receive the intervention, and half the participants will receive usual care with education. Intervention subjects are hypothesized to have significantly less pain-related disability versus usual care subjects after 24 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 8, 2017
CompletedFirst Submitted
Initial submission to the registry
March 19, 2018
CompletedFirst Posted
Study publicly available on registry
April 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2019
CompletedDecember 18, 2024
December 1, 2024
2 years
March 19, 2018
December 13, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Current Pain Intensity on an 11 point scale
Pain intensity is an 11 item scale with a range of 0-11 with a higher score indicating higher pain.
Baseline, 10 weeks
Change in Pain-related disability (RMDQ)
Pain-related disability as measured by the Roland-Morris Disability Questionnaire (RMDQ). This measure has a range of 0-24, with a higher score indicating higher disability.
Baseline, 10 weeks
Secondary Outcomes (3)
Change in Emotion Regulation Mediation (ERQ)
Baseline, 10 and 24 weeks
Client Satisfaction Questionnaire (CSQ)
24 weeks
Change in Montgomery-Asberg Depression Rating Scale (MADRS)
Baseline, 10 and 24 weeks
Study Arms (3)
Path Pain
EXPERIMENTALPath Pain participants will be receiving 8 weekly therapy session by license clinicians trained in the Path Pain intervention. Participants will also receive 4, 15-minute phone booster sessions, on a monthly basis after their final therapy session. Participants will also be invited to monthly group educational sessions. Both intervention and usual care participants will be receiving a pain educational booklet.
Usual Care with Education
NO INTERVENTIONUsual Care with Education (UCE) will receive a pain educational booklet. Following completion of 24 weeks in the study, participants will also be invited to attend the monthly group educational sessions.
Provider Feedback
NO INTERVENTIONProviders of patients in the study will take part in a short interview on their impressions of the intervention.
Interventions
The intervention examines the effects of PATH-Pain on emotion regulation to improve self-management of pain and pain-related disability in older adults with chronic pain, negative emotions, and cognitive impairment. This intervention consists of 8 weekly therapy sessions by a licensed clinician trained in Path Pain, 4 monthly boosters upon completion of therapy, and optional monthly group educational sessions.
Eligibility Criteria
You may qualify if:
- Patient Participants:
- and older
- chronic pain (pain on most days in past 2 months)
- negative emotions
- MoCA score 16 or higher
- Provider Participants:
- providers 18 or over that took care of patient participant
You may not qualify if:
- MoCA score \<16
- cancer related pain
- can not provide capacity to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Weill Medical College of Cornell Universitylead
- Pfizercollaborator
Study Sites (1)
Center on Aging (formerly Wright Center on Aging)
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cary Reid, MD, PhD
Weill Medical College of Cornell University
- PRINCIPAL INVESTIGATOR
Dimitris Kiosses, PhD
Weill Medical College of Cornell University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The co-investigators performing assessments will be blind to the participant's arm.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2018
First Posted
April 4, 2018
Study Start
August 8, 2017
Primary Completion
July 26, 2019
Study Completion
July 26, 2019
Last Updated
December 18, 2024
Record last verified: 2024-12